Correlation Between THC Therapeutics and Abattis Bioceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both THC Therapeutics and Abattis Bioceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining THC Therapeutics and Abattis Bioceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between THC Therapeutics and Abattis Bioceuticals Corp, you can compare the effects of market volatilities on THC Therapeutics and Abattis Bioceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in THC Therapeutics with a short position of Abattis Bioceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of THC Therapeutics and Abattis Bioceuticals.

Diversification Opportunities for THC Therapeutics and Abattis Bioceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between THC and Abattis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding THC Therapeutics and Abattis Bioceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abattis Bioceuticals Corp and THC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on THC Therapeutics are associated (or correlated) with Abattis Bioceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abattis Bioceuticals Corp has no effect on the direction of THC Therapeutics i.e., THC Therapeutics and Abattis Bioceuticals go up and down completely randomly.

Pair Corralation between THC Therapeutics and Abattis Bioceuticals

If you would invest  0.30  in THC Therapeutics on September 20, 2024 and sell it today you would lose (0.23) from holding THC Therapeutics or give up 76.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

THC Therapeutics  vs.  Abattis Bioceuticals Corp

 Performance 
       Timeline  
THC Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in THC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal fundamental indicators, THC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Abattis Bioceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abattis Bioceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Abattis Bioceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

THC Therapeutics and Abattis Bioceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with THC Therapeutics and Abattis Bioceuticals

The main advantage of trading using opposite THC Therapeutics and Abattis Bioceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if THC Therapeutics position performs unexpectedly, Abattis Bioceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abattis Bioceuticals will offset losses from the drop in Abattis Bioceuticals' long position.
The idea behind THC Therapeutics and Abattis Bioceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world